The increase in the plasma levels of free fatty acids (FFAs), TNF-α and IL-6, along with a decrease in adiponectin, together could induce liver and skeletal muscle insulin resistance and dyslipidemia. The gene discussed is ADIPOQ; the disease is Insulin resistance.